Wall Street analysts’ outlook for Verastem Inc. (VSTM)

Verastem Inc. (NASDAQ: VSTM) stock fell -4.72% on Friday to $1.01 against a previous-day closing price of $1.06. With 2.75 million shares changed hands, the volume of the stock remained heavier than its average volume of 1.6 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $1.0600 whereas the lowest price it dropped to was $0.9213. The 52-week range on VSTM shows that it touched its highest point at $3.30 and its lowest point at $1.00 during that stretch. It currently has a 1-year price target of $5.40. Beta for the stock currently stands at 0.71.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of VSTM was down-trending over the past week, with a drop of -16.53%, but this was down by -17.21% over a month. Three-month performance dropped to -18.55% while six-month performance fell -21.09%. The stock lost -66.22% in the past year, while it has lost -50.73% so far this year. A look at the trailing 12-month EPS for VSTM yields -0.43 with Next year EPS estimates of -0.39. For the next quarter, that number is -0.12. This implies an EPS growth rate of 7.60% for this year and 11.40% for next year. EPS is expected to grow by 1.74% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 16.20%.

Float and Shares Shorts:

At present, 186.46 million VSTM shares are outstanding with a float of 186.00 million shares on hand for trading. On Jul 14, 2022, short shares totaled 4.39 million, which was 2.36% higher than short shares on Jun 14, 2022. In addition to Mr. Brian M. Stuglik BPHARM, R.Ph., RPh as the firm’s CEO & Director, Mr. Daniel W. Paterson serves as its COO & Pres.

Institutional Ownership:

Through their ownership of 64.08% of VSTM’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 46.90% of VSTM, in contrast to 28.52% held by mutual funds. Shares owned by individuals account for 11.33%. As the largest shareholder in VSTM with 14.37% of the stake, Baker Bros. Advisors LP holds 26,988,898 shares worth 26,988,898. A second-largest stockholder of VSTM, BVF Partners LP, holds 19,974,658 shares, controlling over 10.64% of the firm’s shares. Viking Global Investors LP is the third largest shareholder in VSTM, holding 9,224,000 shares or 4.91% stake. With a 2.77% stake in VSTM, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 5,204,312 shares are owned by the mutual fund manager. The Carillon Eagle Small Cap Growth F, which owns about 1.84% of VSTM stock, is the second-largest Mutual Fund holder. It holds 3,446,517 shares valued at 4.0 million. Vanguard Extended Market Index Fu holds 1.30% of the stake in VSTM, owning 2,436,568 shares worth 2.83 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for VSTM since 6 analysts follow the stock currently. There are 6 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With VSTM analysts setting a high price target of $8.00 and a low target of $5.00, the average target price over the next 12 months is $5.83. Based on these targets, VSTM could surge 692.08% to reach the target high and rise by 395.05% to reach the target low. Reaching the average price target will result in a growth of 477.23% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. VSTM will report FY 2022 earnings on 03/14/2023. Analysts have provided yearly estimates in a range of -$0.43 being high and -$0.45 being low. For VSTM, this leads to a yearly average estimate of -$0.44. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Verastem Inc. surprised analysts by -$0.01 when it reported -$0.12 EPS against a consensus estimate of -$0.11. The surprise factor in the prior quarter was -$0.01. Based on analyst estimates, the high estimate for the next quarter is -$0.12 and the low estimate is -$0.13. The average estimate for the next quarter is thus -$0.12.

Summary of Insider Activity:

Insiders traded VSTM stock several times over the past three months with 0 Buys and 1 Sells. In these transactions, 0 shares were bought while 5,858 shares were sold. The number of buy transactions has increased to 6 while that of sell transactions has risen to 19 over the past year. The total number of shares bought during that period was 808,000 while 173,158 shares were sold.

Leave a Comment

Your email address will not be published.